Introduction {#sec1-1}
============

Alzheimer\'s disease (AD) is a degenerative disease of the central nervous system characterized by progressive cognitive dysfunction, including impairments in learning, memory and language. AD is strongly associated with perturbed energy metabolism, which is one of the leading causes of neural degeneration, the loss of cerebral neurons, and the formation of senile plaques and neurofibrillary tangles (Cardoso et al., 2004). Reduced glucose utilization and abnormal oxidative metabolism are found in the brain of AD patients, and the decreased metabolism is positively correlated with the severity of dementia (Drzezga et al., 2005; Zhang et al., 2016). Excessive formation and secretion of amyloid-beta, which is a key factor in AD pathogenesis, has a mutually reinforcing relationship with glucose metabolism disorders (Sadowski et al., 2004; Hoyer et al., 2005; Kalpouzos et al., 2005). Insulin signal transduction impairment, glucose metabolism disorder and reduced energy generation also contribute to amyloid-beta deposition and tau hyperphosphorylation, leading to AD (Greenfield et al., 1999; Hoyer, 2000). Before the presence of neuropathological damage and brain atrophy detected by radiological examination, AD patients exhibit abnormal glucose metabolism in the temporal cortex and hippocampus, suggesting that perturbed oxidative phosphorylation (Drzezga et al., 2005), mitochondrial dysfunction and energy metabolism decay are early events in AD. Bucht et al. (1983) found that plasma insulin levels in AD patients were abnormal after oral glucose tolerance test. Subsequent studies demonstrated that, in the fasting state, AD patients have a higher insulin level in the cerebrospinal fluid than normal subjects. Furthermore, AD patients exhibit lower tyrosine kinase activity and impaired insulin signaling, similar to the pathophysiology of non-insulin-dependent diabetes mellitus (De Keyser et al., 1994; Jafferali et al., 2000; Nicolls, 2004). These observations led to the novel proposition that insulin receptor desensitization might play an important role in the pathogenesis of sporadic AD (Gasparini et al., 2002; Watson and Craft, 2003; Carro and Torres-Aleman, 2004; Messier and Teutenberg, 2005; Revill et al., 2006).

Existing drugs for AD include cholinergic agents, nutritional preparations, anti-inflammatory agents, neurotrophic factors, antioxidant drugs and herbal preparations. *Rhodiola crenulata* is a perennial herb in the family Crassulaceae. It is abundantly and widely distributed in China. According to traditional Chinese folk medicine, *Rhodiola crenulata* can improve endurance, resist altitude sickness (Chiu et al., 2013), and treat fatigue, depression, insomnia and impotence (Pooja et al., 2009). A recent study found that *Rhodiola crenulata* supplement strikingly improves aerobic exercise performance after short-term high altitude training (Chen et al., 2014). *Rhodiola crenulata* exerts protective effects on chronic intermittent hypoxia-induced mitochondrial-dependent apoptosis in cardiac cells (Lai et al., 2015). Accumulating evidence indicates that *Rhodiola crenulata* protects against cerebral ischemia-reperfusion injury in the rat brain (Song et al., 2006a, b). Pharmacological studies suggest that *Rhodiola crenulata* promotes cognitive function and relieves brain fatigue (Darbinyan et al., 2000; Spasov et al., 2000), clears reactive oxygen species and reduces oxidative stress (Abidov et al., 2003; Wing et al., 2003; De Sanctis et al., 2004; Battistelli et al., 2005; Kanupriya et al., 2005; Yu et al., 2007; Pooja et al., 2009), enhances physical endurance (Spasov et al., 2000; De Bock et al., 2004), ameliorates metabolic dysfunction (Wang et al., 2012; Tian et al., 2013; Wang et al., 2013), bolsters immunity (Zhu et al., 2014) and exerts anti-tumor effects (Tu et al., 2008). In recent years, *Rhodiola crenulata* has attracted increasing attention because of its cognitive protective effects, antioxidant effects, and ability to scavenge reactive oxygen species (Chen et al., 2012; Zhou et al., 2015).

In our previous study, an edible alcohol extract of *Rhodiola crenulata* root (RCE) protected against spatial cognitive deficits in a rat model of AD induced by intracerebroventricular (ICV) injection of streptozotocin (STZ) (Qu et al., 2009). However, the mechanisms underlying the protective effects of RCE on learning and memory remain unclear. ICV injection of STZ causes a persistent disruption in glucose metabolism and energy production in the brain, leading to learning and memory impairment in rats (Hoyer, 2004; Hoyer and Lannert, 2008). We hypothesized that RCE might protect against mitochondrial dysfunction and improve glucose metabolism and energy production in neurons. Our preliminary studies (Chen et al., 2008a, 2009a; Qin et al., 2008) demonstrated that RCE promotes neural cell proliferation in the dentate gyrus of the hippocampus, and prevents damage to hippocampal neural cells in a rat model of depression induced by chronic stress. In our previous study, RCE pre-administration significantly reduced oxidative stress in the hippocampus of rats administered STZ, accompanied by an improvement in spatial cognitive function (Qu et al., 2009). Furthermore, salidroside (the main active ingredient in RCE) promoted the neuronal differentiation of neural stem cells *in vitro* (Qu et al., 2012). We hypothesized that RCE would exert neuroprotective effects in AD rats by improving mitochondrial function and/or by reducing neuronal apoptosis. In the present study, we investigated the anti-apoptotic effect of RCE and examined its neuroprotective mechanism of action in AD rats, with the aim of providing a rational basis for the use of RCE in the treatment of central neurodegenerative diseases.

Materials and Methods {#sec1-2}
=====================

Preparation of RCE {#sec2-1}
------------------

RCE was provided by Holistol International Co., Ltd., Hong Kong Special Administrative Region, China. The medicinal plant *Rhodiola crenulata* was identified by Professor Ye Huagu of the Herbarium, South China Botanical Garden, The Chinese Academy of Sciences, China. The RCE used in this study is the edible alcohol extract of *Rhodiola crenulata* root, which is a red-brown fine powder, with a rose fragrance. The extraction process is as follows: (1) *Rhodiola crenulata* roots were cleaned and dried; (2) the roots were ground, yielding the powder; (3) the powder was extracted twice using 70% ethanol, 2 hours each, to yield the preliminary extract solution; (4) the solution was concentrated under vacuum; (5) the concentrated solution was precipitated twice using 90% ethanol, yielding a paste; (6) the paste was spray dried, yielding the final RCE powder. The yield was 3--5% (w/w), and the proportion of salidroside in the RCE preparation was 4% (w/w), as determined by high-performance liquid chromatography (HPLC). Certificate of analysis was provided by Sichuan Zhonghong Natural Medicine Co., Ltd., Chengdu, China.

Drug administration {#sec2-2}
-------------------

Ninety adult, female, clean, Sprague-Dawley rats, 5 months old and weighing 220--250 g, were provided by the Experimental Animal Center of Sun Yat-sen University, China (license No. SCXK (Yue) 2009-0011). The rats were allowed free access to standard chow and tap water and housed in cages at 24 ± 2°C in a room with 50--60% relative humidity, under a 12-hour light/dark cycle, for at least 1 week before the experiment. The rats were randomly divided into five groups as follows: normal control group (*n* = 20), AD group (*n* = 20), high-dose RCE group (H-RC group; *n* = 15), moderate-dose RCE group (M-RC group; *n* = 20), and low-dose RCE group (L-RC group; *n* = 15 rats). Rats in the L-RC, M-RC and H-RC groups were respectively administered 1.5, 3.0 and 6.0 g/kg RCE. The RCE was diluted with 0.5% sodium carboxymethycellulose (Guangzhou Pharmaceutical Company, Guangzhou, Guangdong Province, China) water solution to produce working stocks of 1.2, 0.6 and 0.3 g/mL for the H-RC, M-RC and L-RC groups, respectively, and given orally every day at a single dose of 0.5 mL/100 g (body weight) by gavage for 21 days before STZ injection ([**Figure 1**](#F1){ref-type="fig"}). Rats in the AD and normal control groups received an equal amount of 0.5% sodium carboxymethycellulose solution for 21 days.

![Drug administration and procedure for model establishment.](NRR-12-2025-g002){#F1}

AD induced by STZ {#sec2-3}
-----------------

At days 1 and 3 after RCE or sodium carboxymethycellulose administration, a rat model of AD was established using ICV injection of STZ (Sigma, St. Louis, USA) ([**Figure 1**](#F1){ref-type="fig"}). In brief, rats were anesthetized with 1% sodium pentobarbital (40 mg/kg; China Pharmaceutical Group Shanghai Chemical Reagent Company, Shanghai, China) by intraperitoneal injection, and shaved. Their heads were fixed with a stereotaxic apparatus (Jiangwan Instrument Factory, Shanghai, Jiangsu province, China). After the skin was disinfected with iodine and 75% alcohol, a 1.5-cm incision was made along the sagittal line, and the periosteum was cut to expose the cranial bone. Using the Stereotaxic Atlas of the Rat Brain for reference (Bao and Shu, 1991), the skull was drilled 0.8 mm posterior to the bregma and 2.2 mm lateral to the sagittal suture. Thereafter, a microsyringe was vertically inserted to a depth of 4.5 mm. STZ was dissolved in artificial cerebrospinal fluid (147 mM NaCl, 2.9 mM KCl, 1.6 mM MgCl~2~, 1.7 mM CaCl~2~ and 2.2 mM dextrose) to prepare a 25 mg/mL working solution. Rats in the model and RCE groups were injected STZ at a dose of 1.5 mg/kg into the bilateral ventricles (3 μL/100 g body weight for each lateral ventricle). The rats in the normal control group received the same amount of artificial cerebrospinal fluid. Each injection lasted 10 minutes, and the needle was maintained in place for 10 minutes. The suture was disinfected with 0.01% benzalkonium bromide. To prevent infection, rats were given intramuscular penicillin (200,000 U, twice a day, for 3 days).

HPLC assay for ATP content in mitochondria {#sec2-4}
------------------------------------------

### Sample preparation {#sec3-1}

At 21 days after model establishment, 10 rats were decapitated under anesthesia. The brain was rapidly removed on ice, and the hippocampus was quickly dissected and kept at −20°C. The hippocampi were transferred to a glass homogenizer with 0.5 M perchloric acid, 10 μL/mg, and homogenized on ice. The homogenate was kept on ice for 30 minutes and centrifuged at 16,000 × *g* at 4°C for 10 minutes. The pH was adjusted to 7.0 with 0.5 M KOH, placed on ice for 10 minutes, centrifuged and precipitated. The supernatant was stored at −80°C for HPLC detection.

### Chromatography {#sec3-2}

ATP content in the hippocampus was quantitatively detected using reverse HPLC (Waters, Milford, MA, USA). Briefly, a Hypersil BDS C-18 column (4.6 mm ID × 30 mm, 5 μm particle size) was washed with 150 mM NaH~2~PO~4~ buffer solution (pH 6.45, filtered). Then, 20 mL standard solution was added to the column, and the residence time (approximately 13 minutes) was measured. At a wavelength of 254 nm, 20 μL of the sample solution was added and compared with the standard solution for chromatographic analysis.

### Standard curve {#sec3-3}

Taking the peak (μV) as the vertical axis and ATP content as the abscissa, a standard curve was constructed according to the linear equation *Y* = 64,535.14*X* − 7,026.75, *r* = 0.9999.

Detection of mitochondrial cytochrome c oxidase (COX) activity {#sec2-5}
--------------------------------------------------------------

Ten rats in each group were selected for assessment of COX activity. After the hippocampus was isolated and stored at --20°C, the tissue was cut into pieces and homogenized with saline (5% w/v) in a glass homogenizer. The homogenates were centrifuged at 700 × *g* for 16 minutes, and the supernatant was carefully removed. COX activity was determined with a microplate reader (BioRad Model 680, Shanghai, Jiangsu Province, China) using a COX quantitative detection kit (Shanghai Genius U.S. Genetic Medicine Technology Co., Ltd.).

Caspase-3/NeuN double immunofluorescence detection for hippocampal neuronal apoptosis {#sec2-6}
-------------------------------------------------------------------------------------

Five rats in each group were used to obtain hippocampal tissue samples 21 days after model establishment. In brief, rats were intraperitoneally anesthetized with 1% sodium pentobarbital (40 mg/kg), and the heart was fully exposed. A cannula was inserted into the ascending aorta through the left ventricle, and perfused with 120 mL saline, with the right atrium cut for drainage. Pre-cooled 4% paraformaldehyde, approximately 300 mL, was perfused into the heart over a period of 30 minutes. The brain tissue was quickly taken out and fixed with 4% paraformaldehyde at 4°C for 24 hours, and sequentially immersed in 10%, 20% and 30% sucrose at 4°C. Subsequently, the specimens were embedded, and serial coronal slices of the hippocampus were obtained using a cryostat microtome (Thermo Shandon Limited, Altrincham Cheshire, UK). Slices were taken every 300 μm, with thicknesses of 40 and 15 μm. A total of 12 slices were taken from each sample, in two sets.

Five rats in each group were used for immunofluorescence staining, using four slices from each rat, for a total of 20 slices. In brief, the slices were rinsed with 0.01 M PBS and blocked with normal goat serum (1:10; Abcam, Cambridge, UK) for 20 minutes. The slices were then incubated with rabbit anti-rat caspase-3 polyclonal antibody (1:100; Beijing Zhongshan Golden Bridge, Beijing, China). Negative controls were incubated with 0.01 M PBS at 4°C for two nights. The slices were then rinsed with 0.01 M PBS, incubated with goat anti-rabbit IgG-CY3 antibody (1:400; Jackson ImmunoResearch Laboratories, Inc., Pennsylvania, USA) at 37°C for 1 hour, rinsed with 0.01 M PBS, and blocked with normal goat serum (1:10) for 20 minutes. The specimens were incubated with mouse anti-rat NeuN monoclonal antibody (1:100; Chemicon International Inc., Billerica, MA, USA). Negative controls were incubated with 0.01 M PBS at 4°C for two nights. After rinsing with PBS, the specimens were incubated with goat anti-mouse IgG-FITC antibody (1:100; Jackson Immunological Research) at 37°C for 1 hour, rinsed with PBS, mounted, and observed under a fluorescence microscope (Leica Microsystems Inc., Wetzlar, Germany).

Five rats in each group were used for cell counting, using four slices from each rat, for a total of 20 slices. Caspase-3 and NeuN-positive cells in the hippocampal CA3 region were counted under 200× magnification, and the percentage of caspase-3-positive cells to NeuN-positive cells was calculated.

Enzyme histochemistry and electron microscopic observation of mitochondrial COX {#sec2-7}
-------------------------------------------------------------------------------

At 21 days after model induction, five rats each from the normal control, AD and M-RC groups were intraperitoneally anesthetized with 1% sodium pentobarbital (40 mg/kg). The rats were perfused as above, and the brains were fixed with 4% paraformaldehyde/0.5% glutaraldehyde/15% picric acid (0.1 M PB, pH 7.4). The brains were then immersed in 0.1 M phosphate buffer, and cut into 50-μm-thick slices on a vibratome (Zhejiang Xiangshan Science Instrument Factory, Ningbo, China).

The slices were rinsed with 0.1 M phosphate buffer, incubated with 4% sucrose solution (prepared with 0.1 M phosphate buffer) at 37°C for 30 minutes, and incubated with COX reaction mix \[cytochrome c (Sigma) 1.5 mg, 3,3′-diaminobenzidine 2.5 mg, sucrose 200 mg, dissolved in 5 mL 0.1 M phosphate buffer\] at 37°C for 5 hours. After incubation, the specimens were rinsed with phosphate buffer, and the bilateral hippocampal CA3 regions were observed under a stereomicroscope (Leica) and then stored in 0.1 M phosphate buffer for further observation under an electron microscope.

Transmission electron microscopy {#sec2-8}
--------------------------------

\(1\) Fixation: Hippocampal tissue was rinsed with 0.1 M phosphate buffer, fixed with 1% osmic acid for 1 hour, and rinsed again with phosphate buffer. (2) Dehydration: The tissue was dehydrated serially with 50% and 75% ethanol for 15 minutes, twice with 95% ethanol for 15 minutes each, three times with absolute alcohol for 10 minutes each, and three times with anhydrous acetone for 10 minutes each. (3) Permeabilization: The tissue was immersed in embedding liquid (1:1 ratio of Epon812 and acetone) at room temperature for 1 hour, and embedded in pure Epon 812 embedding solution overnight. (4) Embedding and polymerization: The slices were embedded in Epon 812, heated in a 36°C oven, and polymerized for 48 hours. (5) Finally, the slices were cut into ultra-thin slices using an AO ultramicrotome (Leica), stained with 2% uranyl acetate (10 minutes) and lead citrate (3 minutes), and photographed under the electron microscope (PHILIPS CM10, Royal Philips, Amsterdam, Holland).

Statistical analysis {#sec2-9}
--------------------

Data are expressed as the mean ± SD, and analyzed using SPSS 11.5 software (SPSS, Chicago, IL, USA) by one-way analysis of variance. If homogeneity of variance was found, the mean value among groups was compared with the least significant difference test. If heterogeneity of variance was found, the comparison was done using Tamhane\'s T2 test. A value of *P* \< 0.05 was considered statistically significant.

Results {#sec1-3}
=======

Effect of RCE on hippocampal ATP levels in AD rats {#sec2-10}
--------------------------------------------------

As shown in [**Figure 2**](#F2){ref-type="fig"}, hippocampal ATP levels in the M-RC and normal control groups were higher than in the other three groups (*P* \< 0.05). Hippocampal ATP levels were lower in the M-RC group than in the normal control group (*P* \< 0.05). There were no significant differences in hippocampal ATP levels among the AD, L-RC and H-RC groups (*P* \> 0.05).

![Effect of RCE on the levels of ATP (μg/mL) and COX enzymatic activity (U/μg•min) in the hippocampal mitochondria of Alzheimer\'s disease rats.\
Data are expressed as the mean ± SD (*n* = 10), and analyzed by one-way analysis of variance. \**P* \< 0.05, *vs*. normal control group (NC); \#*P* \< 0.05, *vs*. AD group; †*P* \< 0.05, *vs*. L-RC group; §*P* \< 0.05, *vs*. M-RC group. ATP: Adenosine triphosphate; COX: cytochrome c oxidase; RCE: alcohol extract of *Rhodiola crenulata* root; L-RC: low-dose RCE; M-RC: moderate-dose RCE; H-RC: high-dose RCE; AD: Alzheimer\'s disease.](NRR-12-2025-g003){#F2}

Effect of RCE on hippocampal COX levels in AD rats {#sec2-11}
--------------------------------------------------

As shown in [**Figure 2**](#F2){ref-type="fig"}, there was no significant difference in hippocampal COX levels between the AD and H-RC groups (*P* \> 0.05), which were significantly lower than in the other three groups (*P* \< 0.05). Among the normal control, L-RC and H-RC groups, hippocampal COX levels were significantly different for each pairwise comparison (*P* \< 0.05).

Effect of RCE on hippocampal neuronal apoptosis in AD rats {#sec2-12}
----------------------------------------------------------

Hippocampal neuronal apoptosis was detected with caspase-3 and NeuN double immunofluorescence labeling ([**Figure 3A**](#F3){ref-type="fig"}). Caspase-3 and NeuN-positive signals were mainly distributed in the nucleus, and only a small amount was found in the cell body. In the normal control group, NeuN-labeled neurons were morphologically normal and higher in number, and only a few caspase-3-positive cells were observed. In the AD group, a small number of neurons were NeuN-positive, and a large number of caspase-3-positive cells were observed. In the RCE groups, caspase-3-positive cells were reduced to a degree. The M-RC group had the lowest number of caspase-3-positive cells, while the H-RC group had the highest number among the three RCE-administered groups.

![Caspase-3/NeuN immunofluorescence double labeling of cells in the hippocampal CA3 region of Alzheimer\'s disease rats treated with RCE.\
(A) Neuronal apoptosis in the hippocampal CA3 region detected by caspase-3/NeuN double-labeling. Rats in the normal control group (NC) had a small number of caspase-3-positive cells, indicating low neuronal apoptosis, while rats in the AD group had more neuronal apoptosis. Pretreatment with different doses of RCE rescued neurons from apoptosis to varying degrees; the dosage of 3.0 g/kg (in the M-RC group) was optimal. Scale bars: 20 μm. (B) Percentages of caspase-3/NeuN-double-labeled cells in the hippocampal CA3 region of rats in the five different groups. Data are expressed as the mean ± SD (*n* = 5), and analyzed by one-way analysis of variance. \**P* \< 0.05, *vs*. normal control group; \#*P* \< 0.05, *vs*. AD group; †*P* \< 0.05, *vs*. L-RC group; §*P* \< 0.05, *vs*. M-RC group. RCE: Ethanol extract of *Rhodiola crenulata* root; L-RC: low-dose RCE; M-RC: moderate-dose RCE; H-RC: high-dose RCE; AD: Alzheimer\'s disease.](NRR-12-2025-g004){#F3}

The percentage of caspase-3/NeuN-double-labeled cells in the hippocampal CA3 region is shown in [**Figure 3B**](#F3){ref-type="fig"}. This percentage reflects the degree of hippocampal neuronal apoptosis. As shown in [**Figure 3B**](#F3){ref-type="fig"}, there was no significant difference in the percentage of double-labeled cells between the AD and H-RC groups (*P* \> 0.05), and these two groups were significantly different from the other 3 groups (*P* \< 0.05). Among the normal control, L-RC and M-RC groups, there were significant differences in the percentage of double-labeled cells between each pairwise comparison (*P* \< 0.05). The percentage of double-labeled cells was lowest in the normal control group, in-between in the M-RC group, and highest in the L-RC group.

Effect of RCE on mitochondrial COX levels in hippocampal neurons in AD rats {#sec2-13}
---------------------------------------------------------------------------

By electron microscopy, the COX-positive high-electron-dense particles, which represent COX enzymatic activity, were accumulated in the neuronal mitochondrial inner membrane and cristae ([**Figure 4**](#F4){ref-type="fig"}). In the normal control group, mitochondria were small, round or rectangular, with a clearly-defined and uniform matrix, regularly distributed cristae, and a compact structure. A large number of COX-positive particles were visible in the plasma and neurites, as well as in the mitochondrial inner membrane and cristae. In the model group, mitochondrial swelling, a pale gray matrix, and ruptured or blurred cristae were found, and some mitochondrial outer membranes were incomplete or absent, with fewer COX-positive particles on the inner membrane and cristae. After treatment with 3.0 g/kg RCE, however, the decreased COX-positive particles on cristae and the pathological changes in mitochondrial morphology were all improved to a degree. The results are consistent with the ATP and COX levels measured in the homogenates.

![Ultrastructural changes in mitochondria and COX enzyme staining in hippocampal neurons in Alzheimer\'s disease rats treated with RCE (transmission electron microscopy).\
(a) Normal control group; (b) model group; (c) M-RC group. (N: nucleus; C: cytoplasm; M: mitochondria). At 21 days after model establishment, the mitochondria in neurons in the hippocampal CA3 region were examined by COX enzyme histochemistry using electron microscopy. The high-electron-dense COX-positive precipitates accumulated in the mitochondrial inner membrane and cristae represent mitochondrial COX enzymatic activity. Rats in the normal control group showed intact mitochondria with large amounts of discernible COX-positive precipitates. The model group showed strikingly swollen mitochondria, a pale gray matrix, and ruptured or blurred cristae with fewer COX-positive precipitates. The M-RC group showed more COX-positive precipitates and less pathological changes in mitochondria compared to the model group. Inserts: Higher magnification of the boxed area in (a)--(c). Scale bar: 0.5 μm. COX: Cytochrome c oxidase; RCE: ethanol extract of *Rhodiola crenulata* root; M-RC: moderate-dose RCE.](NRR-12-2025-g005){#F4}

Discussion {#sec1-4}
==========

STZ is a nitrosourea derivative, and intraperitoneal injection can cause diabetes mellitus through the destruction of pancreatic β cells (Weiss, 1982; Bolzan and Bianchi, 2002; Kamat, 2015). In the central nervous system, STZ reduces insulin receptor phosphorylation and tyrosine kinase activity, increases tyrosine phosphatase activity and inhibits insulin signaling, thereby impairing glucose and energy metabolism (Hoyer, 1998; Lannert and Hoyer, 1998; Hoyer et al., 2000). The mechanism of STZ cytotoxicity remains unclear, but the alkylating effect of its metabolites can produce reactive oxygen groups, leading to oxidative stress and mitochondrial and nuclear DNA damage (Szkudelski, 2001; Bolzan and Bianchi, 2002; Gille et al., 2002). ICV injection of STZ results in persistent glucose metabolism and energy production disorder in rats, accompanied by reduced hippocampal choline acetyltransferase activity, oxidative stress, and learning and memory disorders (Hoyer and Lannert, 1999, 2008; Shoham et al., 2003; Hoyer, 2004; Sapcanin et al., 2008). Prior to the emergence of hyperglycemia, a series of AD-like pathological changes appears in rodents given ICV injection of STZ, such as brain atrophy and neurodegeneration, loss of central neurons, abnormal activation of glial cells, p53 and GSK-3β activation, hyperphosphorylation of tau protein, elevated amyloid-β levels, and abnormal mitochondrial morphology and function (Grünblatt et al., 2004, 2007; Chu and Qian, 2005; Lester-Coll et al., 2006; Salkovic-Petrisic et al., 2006; Hoyer and Lannert, 2007; Du et al., 2015). Many research groups have used this as a model of sporadic AD (Sharma and Gupta, 2002; Veerendra Kumar and Gupta, 2003; Sonkusare et al., 2005; Shoham et al., 2007; Tahirovic et al., 2007).

Mitochondrial energy metabolism disorder plays a crucial role in neurodegenerative diseases (Blass, 1999; Bubber et al., 2005). Mitochondrial dysfunction promotes and participates in AD occurrence and development, and it is an important factor in the pathogenesis of AD (Lustbader et al., 2004; Hauptmann et al., 2006; Moreira et al., 2006). Mitochondria not only synthesize most of the cell\'s ATP, but they also produce reactive oxygen species, such as superoxide anion, regulate cellular redox potential and signal transduction, and control apoptosis and gene expression (Newmeyer and Ferguson-Miller, 2003).

By electron microscopy, mitochondrial morphology is abnormal in the brain tissue of AD patients. In brain homogenates, the function and expression of several enzyme systems involved in mitochondrial energy generation are affected. Analysis of autopsy samples from AD patients shows that COX activity is decreased in the hippocampus, cerebellum, thalamus and other brain areas (Drzezga et al., 2005). Furthermore, COX activity is decreased, and there are changes in the activities of respiratory chain complexes I and III. Changes in mitochondrial morphology are also found in neurons in the hippocampus, cortex and hypothalamus (Baloyannis, 2006). Morphological abnormalities precede the formation of neurofibrillary tangles, and mitochondrial degeneration may be one of the earliest pathological changes in AD (Maurer et al., 2000; Hirai et al., 2001). Ultrastructural studies show that mitochondria are small in normal neurons, round or columnar in shape, with a dense and uniform matrix, and regular cristae distribution. In comparison, lesioned mitochondria exhibit matrix changes and little or no residual cristae (Baloyannis, 2006).

In previous studies, ICV injection of STZ caused serious oxidative injury and significant spatial learning and memory disorders in the rat hippocampus, and pre-administration of RCE significantly reduced oxidative stress and improved the spatial cognitive defects (Qu et al., 2009). Oxidative stress in cells results in mitochondrial injury, leading to mitochondrial respiratory dysfunction. Mitochondria are the main site of oxidative phosphorylation, and are an important source and target of reactive oxygen species. Mitochondria are prone to free radical attack and oxidative damage to their mitochondrial DNA, particularly as they lack histones, have no proofreading function, and do not have an effective DNA repair mechanism. More than 95% of intracellular reactive oxygen species are generated from mitochondrial oxidative phosphorylation. Mitochondrial dysfunction further increases reactive oxygen species levels, and this vicious cycle results in excessive oxidative stress, eventually leading to neuronal death.

In the present study, we demonstrated that ICV injection of STZ significantly decreases ATP content and COX enzyme activity in the rat hippocampus. Enzyme histochemistry and electron microscopy showed that COX-positive electron-dense particles in the model group were reduced compared with the normal control group, and mitochondrial swelling was found, with no or only residual cristae in the model group. Furthermore, caspase-3-positive signals were observed in the majority of hippocampal neurons in the model group.

Our current findings suggest that ICV injection of STZ in rats induces damage to neuronal mitochondria, thereby leading to neuronal apoptosis. Pre-treatment with RCE increased COX enzyme content and activity, as well as ATP content in the hippocampus. Furthermore, RCE ameliorated neuronal mitochondrial morphology and function, and reduced the percentage of caspase-3-positive cells. This suggests that RCE pre-treatment protects against neuronal apoptosis by preserving neuronal mitochondrial structure and function.

The root and stem of Rhodiola have great therapeutic potential, containing 40 different chemical components. The main pharmacologically active ingredients are salidroside and p-tyrosol, rosavin, pyridine, rhodiosin and rhodionin (Wang and Wang, 1992; Yu et al., 1993; Nakamura et al., 2008). Phytochemical investigations revealed that salidroside, rosavins and p-tyrosol are the most abundant compounds and are thought to account for the therapeutic activities of the plant (Cui et al., 2003). Most studies have focused on the most bioactive ingredient, salidroside (Cui et al., 2003; Nakamura et al., 2008), because of its strong antioxidant activity (Yu et al., 2007). *In vitro* studies have shown that salidroside stimulates erythropoiesis (Qian et al., 2011) promotes hippocampal cell proliferation (Chen et al., 2009b) and promotes the differentiation of bone marrow mesenchymal stem cells into hepatocytes (Ouyang et al., 2010). Furthermore, salidroside prevents apoptosis induced by hydrogen peroxide in human neuroblastoma SH-SY5Y cells (Zhang et al., 2007), reduces reactive oxygen species levels in neural stem cells in the rat hippocampus, ameliorates apoptosis and necrosis, and promotes the proliferation and differentiation of neural stem cells (Qu et al., 2012). Tyrosol is also relatively well studied, as it is an important bioactive ingredient in a variety of foods, such as white wine and olive oil (Di Benedetto et al., 2007; St-Laurent-Thibault et al., 2011). Tyrosol has numerous actions, including antioxidant activity (Di Benedetto et al., 2007; Loru et al., 2009), neural protective functions (Bu et al., 2007), anti-inflammatory effects, anti-tumor effects (Giovannini et al., 2002), and cardio-protective effects (Samuel et al., 2008). However, the actions of rosavins, which include rosavin, rosarin and rosin, remain unclear.

The RCE used in this study is an edible alcohol extract, and the concentration of the most important component, salidroside, was approximately 4% (w/w), as assayed by HPLC. Hence, in the present study, we speculate that the neuroprotective effects of RCE in AD rats are attributable to salidroside. Salidroside possesses a potent reactive oxygen species scavenging function and anti-apoptotic effects. The potential mechanisms underlying the protective effects of salidroside include: (1) modulation of apoptosis-related processes such as alteration of gene expression (e.g. downregulation of the pro-apoptotic gene Bax and/or up-regulation of the anti-apoptotic genes Bcl-2 and Bcl-X(L)) (Yu et al., 2008; Yang et al., 2013), restoration of the mitochondrial membrane potential (Zhang et al., 2010) and suppression of cytochrome c release and caspase cascade activation (Cai et al., 2008); (2) suppression of the excessive entry of Ca^2+^ and the release of calcium stores and inhibition of the elevation in intracellular calcium levels (Cao et al., 2006; Chen et al., 2008b); and (3) inhibition of nitric oxide (NO) synthase activity and reduction of NO production by inhibition of the NF-κB-iNOS-NO signaling pathway (Chen et al., 2009b; Zhang et al., 2011). More studies on the effects of salidroside on the mitochondrial apoptotic pathway are needed to clarify the mechanisms underlying the neuroprotective functions of RCE.

We found that the protective effect of RCE exhibited a parabolic curve pattern, as previously described (Lazarova et al., 1986; Petkov et al., 1986). We found that 0.1 mL RCE significantly improved learning and memory functions in rats, while the 0.02 and 1.0 mL doses had no significant effect. High doses of RCE failed to improve the functions, perhaps because of other components within the extract (Pooja et al., 2009). As mentioned above, RCE contains more than 40 different compounds, and it is possible that other compounds have effects that antagonize those of salidroside. Because of the complexity of herbal extracts, we cannot overcome the potentially adverse effects of other components, which may affect the efficacy of high doses of the extract.

In summary, ICV injection of STZ leads to abnormal changes in mitochondrial structure and function in the rat hippocampus, ultimately resulting in elevated levels of hippocampal neuronal apoptosis. Pretreatment with RCE protects against mitochondrial morphological and functional damage in hippocampal neurons, thereby reducing neuronal apoptosis in the STZ-induced rat model of AD. Our findings provide a basis for future studies on the use of RCE for the treatment of neurodegenerative diseases such as AD.
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